Dishman Pharmaceuticals and Chemicals' subsidiary Carbogen Amcis AG has acquired Creapharm Parenterals. In an interview to CNBC-TV18, VVS Murthy, chief financial officer of Dishman Pharma says, it is a small R&D formulation development company. The acquisition, he says, is funded trough internal accruals.
first published: Jan 19, 2012 02:44 pm
A collection of the most-viewed Moneycontrol videos.

Will Nifty's Upward March Take A Pause As Sentiment Around IT Stocks Weakens? Openign Bell Live

India–US Trade Deal Is Here! Markets Explode, Rupee Soars | What Changes Now?

Live: Sensex, Nifty jumps 2% on India-US deal optimism, Rupees firms up | Closing Bell

India-US Trade Deal Set To Ignite The Bulls| GIFT NIFTY Signals 1000+ Point Gap Up | Opening Bell Live
You are already a Moneycontrol Pro user.